LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Placental Malaria Diagnosed In Poorly Processed Placental Tissue

By LabMedica International staff writers
Posted on 08 Jun 2016
Print article
Image: A photomicrograph of placental tissue revealing the presence of the malarial parasites. The blue arrows point to examples of red blood cells containing pigment and the black arrow points to an example of a pigment-containing histiocyte (Photo courtesy of Drucilla J Roberts, MD).
Image: A photomicrograph of placental tissue revealing the presence of the malarial parasites. The blue arrows point to examples of red blood cells containing pigment and the black arrow points to an example of a pigment-containing histiocyte (Photo courtesy of Drucilla J Roberts, MD).
Placental histopathology has been considered the gold standard for diagnosis of malaria during pregnancy; however, in under-resourced areas placental tissue is often improperly fixed and processed; the resulting formalin pigment is difficult to distinguish from malaria pigment.

It is often problematic to diagnose malaria in pregnant women because parasitized erythrocytes sequestered in the placenta are often absent from the peripheral circulation. Microscopy of peripheral and placental blood, polymerase chain reaction (PCR), and rapid diagnostic tests have been used but vary in sensitivity and specificity.

Scientists the University of North Carolina (Chapel Hill, NC, USA) and their international colleagues performed a prospective study and enrolled 182 adult women with healthy, singleton pregnancies less than 23 weeks gestational age. After delivery, a placental biopsy was collected from an incision at a healthy pericentric area of the placenta. Blood samples were collected from study participants zero to 33 days before delivery.

Real-time quantitative polymerase chain reaction (qPCR) was performed on DNA extracted from filter paper-dried blood spots using a high-throughput pooling strategy. Paraffin sections of approximately 5 µm were stained with Giemsa according to standard histologic protocols. The stained sections were examined by two blinded microscopists under light microscopy to assess parasitemia and malaria pigment. Immunohistochemistry (IHC) was using a monoclonal antibody to Plasmodium falciparum histidine-rich protein 2 (HRP2) was carried out on 5 mm thick, formalin-fixed, paraffin-embedded sections using an automated Bond Leica IHC stainer (Leica Microsystems, Bannockburn, IL, USA).

The sensitivity and specificity of individual tests were calculated using PCR or IHC as the reference standard as well as latent class analysis (LCA). The PCR (at time closest to delivery) was used as the gold standard. With PCR as the reference standard, all of the other tests had high specificities, but low sensitivities. The most sensitive other test was IHC, but it missed 50 % of the malaria infections diagnosed by PCR. The correlation between the two blinded microscopists was poor, as there was widespread formalin pigment. Using LCA, all of the tests had high specificities. The most sensitive test was IHC (67.7%), with PCR as second best (56.1%).

The authors concluded that since IHC can detect parasites when they sequester in the placenta but do not circulate, while PCR detects extremely low parasitemia, the combination of both methods might provide a means of detecting the greatest number of infections. Therefore PCR and/or IHC are suitable diagnostics when the presence of formalin pigment substantially compromises placental histopathology. The study was published on May 10, 2016, in the Malaria Journal.

Related Links:
University of North Carolina
Leica Microsystems
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more